FLGT
Fulgent Genetics Inc

5,717
Mkt Cap
$709.44M
Volume
195,159.00
52W High
$31.04
52W Low
$14.57
PE Ratio
-16.37
FLGT Fundamentals
Price
$23.06
Prev Close
$22.95
Open
$22.96
50D MA
$27.16
Beta
0.77
Avg. Volume
196,010.80
EPS (Annual)
-$1.41
P/B
0.63
Rev/Employee
$215,894.90
$305.49
Loading...
Loading...
News
all
press releases
Fulgent Genetics, Inc. (NASDAQ:FLGT) Given Average Recommendation of "Moderate Buy" by Analysts
Fulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) has been given an average recommendation of "Moderate Buy" by the five analysts that are currently covering the stock, Marketbeat reports. One...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Doximity (DOCS) Q3 Earnings and Revenues Surpass Estimates
Doximity (DOCS) delivered earnings and revenue surprises of +4.55% and +2.23%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5d ago
News Placeholder
New Strong Buy Stocks for January 12th
ERO, NU, KSS, FLGT and BODI have been added to the Zacks Rank #1 (Strong Buy) List on Jan.12, 2026.
Zacks·30d ago
News Placeholder
Squarepoint Ops LLC Cuts Position in Fulgent Genetics, Inc. $FLGT
Squarepoint Ops LLC decreased its position in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 69.6% during the 2nd quarter, according to the company in its most recent disclosure with the...
MarketBeat·2mo ago
News Placeholder
FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform
Fulgent is set to buy Bako Diagnostics assets and StrataDx for $55.5M, expanding into anatomic pathology and dermatopathology to scale lab services.
Zacks·2mo ago
News Placeholder
Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx
Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it has...
Business Wire·2mo ago
News Placeholder
Fulgent Genetics (NASDAQ:FLGT) Rating Lowered to "Hold" at Wall Street Zen
Wall Street Zen downgraded shares of Fulgent Genetics from a "buy" rating to a "hold" rating in a research note on Saturday...
MarketBeat·2mo ago
News Placeholder
Diametric Capital LP Makes New $3.36 Million Investment in Fulgent Genetics, Inc. $FLGT
Diametric Capital LP bought a new stake in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and...
MarketBeat·2mo ago
News Placeholder
Jian Xie Sells 1,140 Shares of Fulgent Genetics (NASDAQ:FLGT) Stock
Fulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) COO Jian Xie sold 1,140 shares of the company's stock in a transaction dated Tuesday, December 2nd. The shares were sold at an average price of...
MarketBeat·2mo ago
News Placeholder
Fulgent Genetics (NASDAQ:FLGT) Insider Sells $30,454.75 in Stock
Fulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) insider Hanlin Gao sold 1,075 shares of Fulgent Genetics stock in a transaction dated Tuesday, December 2nd. The stock was sold at an average...
MarketBeat·2mo ago
<
1
2
...
>

Latest FLGT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.